State Street’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-836,915
| Closed | -$23.4M | – | 5028 |
|
|
2022
Q1 | $23.4M | Sell |
836,915
-112,755
| -12% | -$3.09M | ﹤0.01% | 2282 |
|
|
2021
Q4 | $25.9M | Sell |
949,670
-70,062
| -7% | -$1.9M | ﹤0.01% | 2276 |
|
|
2021
Q3 | $27.7M | Buy |
1,019,732
+12,422
| +1% | +$307K | ﹤0.01% | 2241 |
|
|
2021
Q2 | $17.2M | Buy |
1,007,310
+69,934
| +7% | +$1.31M | ﹤0.01% | 2592 |
|
|
2021
Q1 | $19.6M | Buy |
937,376
+57,251
| +7% | +$1.32M | ﹤0.01% | 2382 |
|
|
2020
Q4 | $20.2M | Buy |
880,125
+174,277
| +25% | +$3.32M | ﹤0.01% | 2234 |
|
|
2020
Q3 | $11.5M | Sell |
705,848
-98,219
| -12% | -$1.78M | ﹤0.01% | 2368 |
|
|
2020
Q2 | $10.9M | Buy |
804,067
+82,589
| +11% | +$961K | ﹤0.01% | 2375 |
|
|
2020
Q1 | $8.55M | Buy |
721,478
+8,631
| +1% | +$191K | ﹤0.01% | 2368 |
|
|
2019
Q4 | $17.8M | Sell |
712,847
-13,925
| -2% | -$282K | ﹤0.01% | 2225 |
|
|
2019
Q3 | $12.4M | Buy |
726,772
+35,130
| +5% | +$639K | ﹤0.01% | 2359 |
|
|
2019
Q2 | $15.7M | Buy |
691,642
+26,283
| +4% | +$709K | ﹤0.01% | 2259 |
|
|
2019
Q1 | $21.4M | Buy |
665,359
+1,725
| +0.3% | +$53.4K | ﹤0.01% | 1986 |
|
|
2018
Q4 | $18.7M | Sell |
663,634
-23,745
| -3% | -$695K | ﹤0.01% | 2026 |
|
|
2018
Q3 | $19.8M | Buy |
687,379
+74,348
| +12% | +$2.23M | ﹤0.01% | 2186 |
|
|
2018
Q2 | $23M | Buy |
613,031
+14,765
| +2% | +$580K | ﹤0.01% | 2048 |
|
|
2018
Q1 | $23.5M | Buy |
598,266
+28,584
| +5% | +$1.04M | ﹤0.01% | 1931 |
|
|
2017
Q4 | $18.5M | Sell |
569,682
-14,939
| -3% | -$448K | ﹤0.01% | 2101 |
|
|
2017
Q3 | $18.2M | Buy |
584,621
+32,277
| +6% | +$955K | ﹤0.01% | 2091 |
|
|
2017
Q2 | $15.4M | Buy |
552,344
+138,968
| +34% | +$3.15M | ﹤0.01% | 2165 |
|
|
2017
Q1 | $7.09M | Sell |
413,376
-45,951
| -10% | -$644K | ﹤0.01% | 2532 |
|
|
2016
Q4 | $5.55M | Buy |
459,327
+51,973
| +13% | +$673K | ﹤0.01% | 2638 |
|
|
2016
Q3 | $6.45M | Buy |
407,354
+26,570
| +7% | +$400K | ﹤0.01% | 2419 |
|
|
2016
Q2 | $4.92M | Sell |
380,784
-27,434
| -7% | -$429K | ﹤0.01% | 2598 |
|
|
2016
Q1 | $7.76M | Sell |
408,218
-69,460
| -15% | -$1.26M | ﹤0.01% | 2316 |
|
|
2015
Q4 | $10.8M | Sell |
477,678
-565,507
| -54% | -$11.2M | ﹤0.01% | 2142 |
|
|
2015
Q3 | $24.4M | Buy |
1,043,185
+881,889
| +547% | +$24.3M | ﹤0.01% | 1627 |
|
|
2015
Q2 | $4.62M | Buy |
161,296
+93,467
| +138% | +$2.45M | ﹤0.01% | 2661 |
|
|
2015
Q1 | $1.75M | Buy |
67,829
+16,329
| +32% | +$373K | ﹤0.01% | 3071 |
|
|
2014
Q4 | $958K | Buy |
51,500
+9,200
| +22% | +$166K | ﹤0.01% | 3272 |
|
|
2014
Q3 | $656K | Buy |
+42,300
| New | +$637K | ﹤0.01% | 3339 |
|
State Street's XENT Position: Q2 2022 in Review
State Street sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 836,915 shares — an estimated $23.4M sold.
State Street first reported a position in XENT in Q3 2014 and held it in 31 quarters. The position peaked at $27.7M in Q3 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- State Street reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- State Street sold 836,915 Intersect ENT, Inc shares in Q2 2022, an estimated $23.4M.
- State Street first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 31 quarters.
- State Street's Intersect ENT, Inc position peaked at $27.7M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.